Brennan Aoife

SEC CIK: 0001714563

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $407.0K and no purchases.

Current role at each company

CLYM Climb Bio, Inc.President and CEOas of Jun 30, 2026
XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2026
KYNB Kyntra Bio, Inc.Directoras of Jun 6, 2024
SYBX Synlogic, Inc.President and CEOas of Nov 14, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $407.0K; 1 filing
Net: −$407.0K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Brennan Aoife as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

CLYM Climb Bio, Inc.

President and CEO2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jun 30, 2026 (view filing)	Jun 29	1 day	Brennan AoifePresident and CEO	SSale	−30.9K	$13.17	−$407.0K	−26.0%87.7K after	10b5-1
Jul 1, 2025 (view filing)	Jun 30	1 day	Brennan AoifePresident and CEO	SSale	−20.6K	$1.22	−$25.2K	−30.0%48.1K after	10b5-1

KYNB Kyntra Bio, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jun 9, 2023 (view filing)	Jun 9	Same day	Brennan AoifeDirector	SSale	−4.73K	$17.19	−$81.4K	−14.5%27.9K after	2 lots10b5-1

SYBX Synlogic, Inc.